ANTB
BEAM icon

AMG National Trust Bank’s Beam Therapeutics BEAM Stock Holding History

AMG National Trust Bank’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587K Hold
17,107
– – 0.01% 311
2026
Q1 		$408K Buy
17,107
+100
+0.6% +$2.77K 0.01% 392
2025
Q4 		$471K Hold
17,007
– – 0.01% 352
2025
Q3 		$413K Hold
17,007
– – 0.01% 363
2025
Q2 		$289K Buy
+17,007
New +$296K 0.01% 390

Other funds holding BEAM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

AMG National Trust Bank's BEAM Position: Q2 2026 in Review

AMG National Trust Bank held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 17,107 shares worth $587K. The position accounts for 0.01% of the portfolio, ranked #311.

AMG National Trust Bank first reported a position in BEAM in Q2 2025 and has held it in 5 quarters since. 105 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • AMG National Trust Bank held 17,107 shares of Beam Therapeutics worth $587K as of Q2 2026.
  • AMG National Trust Bank left its Beam Therapeutics share count unchanged in Q2 2026.
  • Beam Therapeutics made up 0.01% of AMG National Trust Bank's portfolio in Q2 2026, its #311 holding.
  • AMG National Trust Bank first reported a position in Beam Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 105 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.